Brenner Tumor - 50 Studies Found Estado Estudiar Completed Nombre del estudio: Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer Condición: Brenner Tumor Ovarian Clear Cell Cystadenocarcinoma Fecha: 1999-11-01 Intervenciones: Drug: paclitaxel Given IV Completed Nombre del estudio: Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin Condición: Brenner Tumor Fallopian Tube Cancer Drug: belinostat Given IV Completed Nombre del estudio: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy Condición: Brenner Tumor Fallopian Tube Cancer Biological: sargramostim Given Completed Nombre del estudio: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma Condición: Brenner Tumor Fallopian Tube Cancer Drug: paclitaxel Given IV Recruiting Nombre del estudio: Metformin Hydrochloride and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condición: Brenner Tumor Malignant Ascites Drug: paclitaxel Given IV Completed Nombre del estudio: Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) Condición: Brenner Tumor Fallopian Tube Cancer Drug: carboplatin Given intrap Completed Nombre del estudio: Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Condición: Brenner Tumor Fallopian Tube Cancer Procedure: adjuvant therapy Drug: paclitax Recruiting Nombre del estudio: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Condición: Ovarian Brenner Tumor Ovarian Carcinosarcoma Drug: Gemcitabine Hydrochloride Completed Nombre del estudio: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer Condición: Malignant Ovarian Mixed Epithelial Tumor Ovarian Brenner Tumor< Fecha: 2011-02-10 Intervenciones: Drug: TLR8 Agonist VTX-2337 Gi Suspended Nombre del estudio: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer Condición: Nausea and Vomiting Ovarian Brenner Tumor Procedure: Adjuvant Therapy An Next >>>